NHS fast-tracks new targeted drug for rare lung cancer
Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery
Read More
Author: John Pinching
New research suggests women less likely to receive support for cardiogenic shock
Research analysed differences in treatment and survival between women and men with a heart attack and cardiogenic shock
Read More
Finalists announced for the 2022 International Clinical Researcher of the Year
With the significant increase in entries this year, the competition to name the finalists proved incredibly tough. The International Clinical Researcher judging panel, however, have made their decisions and the finalists have now been announced.
Read More
AstraZenca’s antibody cocktail Evusheld receives MHRA authorisation
Approval is significant as waning restrictions present significant threats to many immunocompromised people across the UK
Read More
Scientists identify two more hybrid variants alongside Deltacron
The hybrid of Delta and Omicron, known as ‘Deltacron’, has been identified in France, Denmark and the Netherlands
Read More- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
